Sanofi (SNY) Other Non Operating Income (2013 - 2018)

Sanofi has disclosed Other Non Operating Income across 6 years of filings, most recently posting -$239.7 million for Q4 2018.

• Other Non Operating Income for Q4 2018 came in at -$239.7 million, down 146.91% year-over-year; the trailing twelve-month figure through Dec 2018 was -$777.8 million (up 34.87% YoY), and the FY2016 annual result was -$212.6 million, up 75.08% from the prior year.
• Other Non Operating Income came in at -$239.7 million for Q4 2018 at Sanofi, down from $511.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $511.0 million in Q4 2017 to a low of -$841.8 million in Q4 2015.
• The 5-year median for Other Non Operating Income is -$239.7 million (2018), against an average of -$286.8 million.
• Across the five-year window, Other Non Operating Income plunged 235.8% in 2014 and surged 346.5% in 2017, its largest moves.
• Sanofi's Other Non Operating Income stood at -$656.2 million in 2014, then fell by 28.29% to -$841.8 million in 2015, then soared by 75.37% to -$207.3 million in 2016, then surged by 346.5% to $511.0 million in 2017, then slumped by 146.91% to -$239.7 million in 2018.
• The last three Other Non Operating Income figures came in at -$239.7 million (Q4 2018), $511.0 million (Q4 2017), and -$207.3 million (Q4 2016), per Business Quant data.